The Effectiveness of Inflammatory Indexes in Assessing Oropharyngeal Cancer Prognosis

Abstract

Abstract Background Inflammation has long been a key tenet in the diagnosis and management of malignancies, likely contributing to cancer incidence, staging, and progression. Systemic inflammation, in particular, is often elevated prior to and during cancer development. Systemic inflammation in the context of cancer diagnosis and monitoring is measured by various inflammatory indexes such as Systemic inflammatory response index (SIRI), plasma-to-lymphocyte ratio (PLR), systemic immune inflammation index (SII), and neutrophil-to-lymphocyte ratio (NLR). We set out to determine the relationship between pre and posttreatment levels of these inflammatory indexes and the prognosis and outcomes of oropharyngeal cancer (OPC). Methods A retrospective chart review was performed of 172 patients with OPC who underwent treatment for oropharyngeal cancer at University Medical Center between May 2013 to May 2023. Sites of primary cancer were obtained through chart review. HPV infection status and differentiation of the tumor were noted for each patient. Treatment modalities were classified as surgery, radiation, chemotherapy, or concurrent chemotherapy and radiation. Treatment outcomes were classified based on recurrence and death secondary to disease. The relationships between treatment outcome and the described inflammatory indexes were evaluated. Appropriate parametric tests were selected based on the large number of variables. Results Pretreatment SIRI and Albumin levels were positively predictive in determining locoregional recurrence (p = .031 and p = .039). NLR, SII, and SIRI levels taken at three months post-treatment were also found to be positively predictive of locoregional recurrence (p = .005, p > .0005, and p = .007). SIRI taken at six months post-treatment was also found to be positively predictive of locoregional recurrence (p = .008). SII at six months post-treatment was found to be positively predictive of survival (p = .027). Conclusions This study suggested that post-treatment levels of several inflammatory indexes, particularly SIRI, NLR, and SII, may be useful in determining the long-term outlook and recurrence of head and neck cancer following treatment.